Rapid COVID-19 rebound in a severe COVID-19 patient during 20-day course of Paxlovid.

Wang, Yu; Chen, Xubo; Xiao, Wenying; Zhao, Danyang; Feng, Liuliu

Wang, Yu; Chen, Xubo; Xiao, Wenying; Zhao, Danyang; Feng, Liuliu.

Afiliação

Wang Y; Department of Cardiology, Shidong Hospital, Yangpu District, Shidong Hospital affiliated to University of Shanghai for Science and Technology, 999 Shiguang Road, Shanghai 200438, China. Electronic address: wangyushidonghos@163.com.
Chen X; Department of Cardiology, Shidong Hospital, Yangpu District, Shidong Hospital affiliated to University of Shanghai for Science and Technology, 999 Shiguang Road, Shanghai 200438, China; Department of Rehabilitation medicine, Shidong Hospital, Yangpu District, Shidong Hospital affiliated to Universit
Xiao W; Department of Cardiology, Shidong Hospital, Yangpu District, Shidong Hospital affiliated to University of Shanghai for Science and Technology, 999 Shiguang Road, Shanghai 200438, China.
Zhao D; Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhizaoju Road, Shanghai 200011, China. Electronic address: drzhaodanyang@126.com.
Feng L; Department of Cardiology, Shidong Hospital, Yangpu District, Shidong Hospital affiliated to University of Shanghai for Science and Technology, 999 Shiguang Road, Shanghai 200438, China. Electronic address: Llf20170101@usst.edu.cn.

J Infect ; 85(5): e134-e136, 2022 11.

Article em En | MEDLINE | ID: mdl-35995309

Assuntos

COVID-19; Combinação de Medicamentos; Humanos; Lactamas; Leucina; Nitrilas; Prolina; Ritonavir

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google